Improved monitoring to detect liver cancer early in high-risk patients
Monitoring high-risk patients to detect liver cancer early has improved by around a third at an NHS trust in Kent and Medway.
Medway NHS Foundation Trust's (MFT) team has put in place a system to support regular scans for people at increased risk of liver cancer, particularly those with cirrhosis or other long-term liver conditions.
The system provides a more structured way of tracking patients and as a result, the service has achieved a significant improvement with scanning rates rising from 67 per cent to 90 per cent.
This means more patients are receiving surveillance in line with clinical guidance and are less likely to miss important monitoring appointments.
This Liver Cancer Awareness Month, the MFT team will present their work at the British Association for the Study of the Liver' (BASL) conference on 8 October.
Patient outcomes
The work is part of the Kent and Medway Cancer Alliance's Liver Surveillance Programme.
Kent and Medway Cancer Alliance's Primary Care Clinical Lead for Cancer Dr Jonathan Bryant said: "Earlier detection of liver cancer can save lives.
"By making sure patients receive regular checks at the right time, the team is helping more people get diagnosed earlier, access treatment sooner and improve their chances of a successful outcome.”
Hepatology Clinical Nurse Specialist (CNS) Louise Eales, CNS Selwyn Semple and liver navigator Michelle Talabi are part of the team that has put the new system in place.
Louise, who is attending the conference, said: "For patients at increased risk of liver cancer, including those with cirrhosis, advanced liver fibrosis, hepatitis B and hepatitis C, regular monitoring can make a life-changing difference. This includes ultrasound scans and blood tests every six months to check for any early signs of cancer.
"Detecting cancer at an earlier stage often means patients have access to more treatment options and a much better chance of successful treatment.
“Our new system helps ensure patients receive the checks they need at the right time, giving them the best possible opportunity for an early diagnosis and access to treatment."
Liver Surveillance Programme
Liver Surveillance Programme aims to identify signs of liver cancer as early as possible, when treatment options can be more effective and outcomes better.
The surveillance involves regular abdominal ultrasound scans every six months to detect liver cancer early in high-risk patients.
Patients on the programme are monitored regularly, typically through ultrasound scans and blood tests.
Because surveillance involves managing large numbers of patients over many years, accurate tracking and correctly timed invitations for appointments are essential.
National recognition
The improvements at MFT contributed to the trust achieving a nationally recognised quality mark for liver services last year.
Improving Quality in Liver Services (IQILS) is a nationally recognised quality mark for liver services, providing independent assurance that high standards of patient care, safety, and continuous improvement are being delivered.
More details can be found on the Medway NHS Foundation Trust website.
Notes to editors
- For further information and interview requests, please email the Kent and Medway Cancer Alliance team at mtw-tr.englandkmcanceralliance@nhs.net
- More information on Kent and Medway Cancer Alliance is available on the website www.kentandmedwaycanceralliance.nhs.uk